A systematic review of lenvatinib and sorafenib for treating progressive, locally advanced or metastatic, differentiated thyroid cancer after treatment with radioactive iodine

BACKGROUND: Treatment with radioactive iodine is effective for many patients with progressive, locally advanced or metastatic, differentiated thyroid cancer. However, some patients become refractory to treatment. These types of patients are considered to have radioactive iodine refractory differenti...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleeman, Nigel, Houten, Rachel, Chaplin, Marty, Beale, Sophie, Boland, Angela, Dundar, Yenal, Greenhalgh, Janette, Duarte, Rui, Shenoy, Aditya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909631/
https://www.ncbi.nlm.nih.gov/pubmed/31830943
http://dx.doi.org/10.1186/s12885-019-6369-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6909631/
https://www.ncbi.nlm.nih.gov/pubmed/31830943
http://dx.doi.org/10.1186/s12885-019-6369-7

Ejemplares similares